Eyes On 2027 sets sail next week!

Eyes On 2027 sets sail next week!

Final boarding call! Eyes On 2027 embarks November 6-7, and there’s still a spot on deck for you. Sign up now for 12 virtual clinical sessions covering the most critical eyecare advances across every specialty. Plus, earn up to 8 COPE-accredited CE hours, ask experts questions live, and enter to win up to $2,000 in raffle prizes!

Recently Published
In the Hot Seat: A Live Q&A Regarding All Things Retina
RETINAL DISEASE
In the Hot Seat: A Live Q&A Regarding All Things Retina

Carolyn Majcher, OD, FAAO, FORS, answers questions from Eyes On Retina 2026 attendees regarding anything and everything retina.

Advancements in Non-Invasive Imaging for Dry Eye Disease
DIAGNOSTICS & IMAGING
Advancements in Non-Invasive Imaging for Dry Eye Disease

Explore the latest non-invasive imaging technologies for dry eye disease, plus practical strategies for integrating them into your practice.

How DTC Advertising is Driving Presbyopia Drop Conversations in Practice
PRESBYOPIA
How DTC Advertising is Driving Presbyopia Drop Conversations in Practice

Joins Drs. Coats, Davison, Ramsey and Schaeffer to review how direct-to-consumer (DTC) advertising impacts patient conversations about presbyopia drops.

Stabilizing the Tear Film Prior to Cataract Surgery

Stabilizing the Tear Film Prior to Cataract Surgery

Sit down with Drs. Preeya K. Gupta and Vance Thompson to review approaches for efficiently addressing tear film instability before cataract surgery.

Learn More
Latest Stories
Glaukos and RevOpsis partner on retina tri-specific therapy development, commercialization
November 6, 2026
Glaukos and RevOpsis partner on retina tri-specific therapy development, commercialization

Exclusive licensing agreement also extends up to four retinal biologics.

Dexamethasone eye drops may cut invasive ROP treatment in preterm infants
November 5, 2026
Dexamethasone eye drops may cut invasive ROP treatment in preterm infants

A 47% relative risk reduction fell short of statistical significance, but the safety data keep topical steroids in play as a noninvasive option.

Nacuity doses first patient in phase 3 trial on oral therapy for RP associated with Usher syndrome
November 5, 2026
Nacuity doses first patient in phase 3 trial on oral therapy for RP associated with Usher syndrome

Sites in the U.S. and Australia are actively enrolling patients for the SLO-RP Preserve trial.

Clinical
Barriers to Oculomics and How to Overcome Them
PRODUCTS & TECHNOLOGY
Barriers to Oculomics and How to Overcome Them

Consider key challenges in the adoption and implementation of oculomics, such as settling regulatory, legal, and reimbursement questions, and more.

Matlock Wyman, ODNovember 6, 2026
Clinical Impact of Demodex Blepharitis with Interactive Calculator
CLINICAL GUIDES
Clinical Impact of Demodex Blepharitis with Interactive Calculator

Learn how to recognize, fully treat, and follow up Demodex blepharitis before it compromises cataract and refractive outcomes.

The Ultimate Guide to TOTAL30® Multifocal for Astigmatism
PRIMARY CARE
The Ultimate Guide to TOTAL30® Multifocal for Astigmatism

Drs. Cifuentes and Lagunas offer insight into TOTAL30® Multifocal for Astigmatism, a modern solution designed for presbyopic patients with astigmatism, providing comfort and clear vision for both distance and near tasks.1

Careers
How DTC Advertising is Driving Presbyopia Drop Conversations in Practice
PRESBYOPIA
How DTC Advertising is Driving Presbyopia Drop Conversations in Practice

Joins Drs. Coats, Davison, Ramsey and Schaeffer to review how direct-to-consumer (DTC) advertising impacts patient conversations about presbyopia drops.

How I Made CareCredit Simple for My Team and Patients
FINANCE
How I Made CareCredit Simple for My Team and Patients

Dr. Brianna Rhue shares practical ways eyecare practice teams can simplify CareCredit for staff and patients through training, workflows, patient conversations, and performance tracking.

The Impact of Presbyopia Drops on Optical Sales
PRACTICE MANAGEMENT
The Impact of Presbyopia Drops on Optical Sales

Join Drs. Schaeffer and Chima as they discuss the impact of prescribing presbyopia drops on optical sales and patient care in clinical practice.

Sponsored Content
The Ultimate Guide to TOTAL30® Multifocal for Astigmatism
PRIMARY CARE

The Ultimate Guide to TOTAL30® Multifocal for Astigmatism

Drs. Cifuentes and Lagunas offer insight into TOTAL30® Multifocal for Astigmatism, a modern solution designed for presbyopic patients with astigmatism, providing comfort and clear vision for both distance and near tasks.1

Our industry partners

ZEISS
National Vision
EssilorLuxottica
Essilor
Johnson & Johnson Vision
ZEISS Professional Education

Find your next eyecare job

Browse Eyecare Jobs (1,000+)Post a Job

Find your next eyecare job